|
1.
|
|
18 p, 1.0 MB |
Assessing Associations between the AURKA-HMMR-TPX2-TUBG1 Functional Module and Breast Cancer Risk in BRCA1/2 Mutation Carriers
/
Blanco Guillermo, Ignacio (Institut d'Investigació Biomèdica de Bellvitge) ;
Kuchenbaecker, Karoline (University of Cambridge) ;
Cuadras, Daniel (Institut d'Investigació Biomèdica de Bellvitge) ;
Wang, Xianshu (Mayo Clinic, Rochester, United States of America) ;
Barrowdale, Daniel (University of Cambridge) ;
de Garibay, Gorka Ruiz (Institut d'Investigació Biomèdica de Bellvitge) ;
Librado, Pablo (Universitat de Barcelona) ;
Sánchez-Gracia, Alejandro (Universitat de Barcelona) ;
Rozas, Julio (Universitat de Barcelona) ;
Bonifaci, Núria (Institut d'Investigació Biomèdica de Bellvitge) ;
McGuffog, Lesley (University of Cambridge) ;
Pankratz, Vernon S. (Mayo Clinic, Rochester, Minnesota) ;
Islam, Abul (University of Dhaka) ;
Mateo, Francesca (Institut d'Investigació Biomèdica de Bellvitge) ;
Berenguer-Llergo, Antoni (Institut d'Investigació Biomèdica de Bellvitge) ;
Petit Montserrat, Anna (Institut d'Investigació Biomèdica de Bellvitge) ;
Català, Isabel (Institut d'Investigació Biomèdica de Bellvitge) ;
Brunet, Joan (Institut d'Investigació Biomèdica de Girona) ;
Feliubadaló, Lidia (Institut d'Investigació Biomèdica de Bellvitge) ;
Tornero, Eva (Institut d'Investigació Biomèdica de Bellvitge) ;
Benitez, Javier (Centro Nacional de Investigaciones Oncológicas) ;
Osorio, Ana (Centro Nacional de Investigaciones Oncológicas) ;
Ramon y Cajal, Teresa (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ;
Aittomäki, Kristiina (Helsinki University Central Hospital) ;
Arun, Banu K. (University of Texas) ;
Toland, Amanda E. (The Ohio State University, Columbus) ;
Karlan, Beth Y. (Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Los Angeles) ;
Walsh, Christine (Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Los Angeles) ;
Lester, Jenny (Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Los Angeles) ;
Greene, Mark H. (National Cancer Institute, Maryland, Rockville) ;
Mai, Phuong L. (National Cancer Institute, Maryland, Rockville) ;
Nussbaum, Robert L. (University of California San Francisco, San Francisco) ;
Andrulis, Irene L. (Samuel Lunenfeld Research Institute, Mount Sinai Hospital, and Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada) ;
Domchek, Susan M. (The University of Pennsylvania School of Medicine, Philadelphia) ;
Nathanson, Katherine L. (The University of Pennsylvania School of Medicine, Philadelphia) ;
Rebbeck, Timothy R. (Abramson Cancer Center and Center for Clinical Epidemiology and Biostatistics, The University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, United States of America) ;
Barkardottir, Rosa B. (Landspitali University Hospital (Reykjavík, Islàndia)) ;
Jakubowska, Anna (Pomeranian Medical University, Szczecin) ;
Lubinski, Jan (Pomeranian Medical University, Szczecin) ;
Durda, Katarzyna (Pomeranian Medical University, Szczecin) ;
Jaworska-Bieniek, Katarzyna (Pomeranian Medical University, Szczecin) ;
Claes, Kathleen (Ghent University, Ghent) ;
Van Maerken, Tom (Ghent University, Ghent) ;
Diez, Orland (Vall d'Hebron Institut d'Oncologia) ;
Hansen, Thomas V. (Copenhagen University Hospital) ;
Jønson, Lars (Copenhagen University Hospital) ;
Gerdes, Anne-Marie (Copenhagen University Hospital) ;
Ejlertsen, Bent (Copenhagen University Hospital) ;
De la Hoya, Miguel (Instituto de Investigación Sanitaria del Hospital Clínico San Carlos) ;
Caldes, Trinidad (Instituto de Investigación Sanitaria del Hospital Clínico San Carlos) ;
Dunning, Alison M. (University of Cambridge) ;
Oliver, Clare (University of Cambridge) ;
Fineberg, Elena (University of Cambridge) ;
Cook, Margaret (University of Cambridge) ;
Peock, Susan (University of Cambridge) ;
McCann, Emma (Glan Clwyd Hospital, Rhyl) ;
Murray, Alex (Singleton Hospital, Swansea) ;
Jacobs, Chris (Guy's and St. Thomas' National Health Service, London) ;
Pichert, Gabriella (Guy's and St. Thomas' National Health Service, London) ;
Lalloo, Fiona (Central Manchester University Hospitals National Health Service, Manchester) ;
Chu, Carol (Yorkshire Regional Genetics Service, Leeds) ;
Dorkins, Huw (Kennedy-Galton Centre, Harrow) ;
Paterson, Joan (Addenbrookes Hospital (Cambridge, Regne Unit)) ;
Ong, Kai-Ren (Birmingham Women's Hospital) ;
Teixeira, Manuel R. (Universidade do Porto) ;
Hogervorst, Frans B. L. (The Netherlands Cancer Institute (Amsterdam, Països Baixos)) ;
van der Hout, Annemarie H. (University of Groningen) ;
Seynaeve, Caroline (Erasmus University Medical Center, Rotterdam) ;
van der Luijt, Rob B. (University Medical Center Utrecht, Utrecht) ;
Ligtenberg, Marjolijn J. L. (Radboud university medical center, Nijmegen) ;
Devilee, Peter (Leiden University Medical Center, Leiden) ;
Wijnen, Juul T. (Leiden University Medical Center, Leiden) ;
Rookus, Matti A. (The Netherlands Cancer Institute (Amsterdam, Països Baixos)) ;
Meijers-Heijboer, Hanne E. J. (Vrije Universiteit, Amsterdam) ;
Blok, Marinus J. (Maastricht University Medical Center) ;
van den Ouweland, Ans M. W. (Erasmus University Medical Center, Rotterdam) ;
Aalfs, Cora M. (Department of Clinical Genetics, Amsterdam) ;
Rodriguez, Gustavo C. (University of Chicago) ;
Phillips, Kelly-Anne A. (Peter MacCallum Cancer Centre, East Melbourne) ;
Piedmonte, Marion (Roswell Park Cancer Institute, Buffalo, New York) ;
Nerenstone, Stacy R. (Hartford Hospital/Helen and Harry Gray Cancer Center) ;
Bae-Jump, Victoria L. (University of North Carolina) ;
O'Malley, David M. (Ohio State University, Hilliard) ;
Ratner, Elena S. (Yale University School of Medicine) ;
Schmutzler, Rita K. (Uniklinik Köln (Colònia, Alemanya)) ;
Wappenschmidt, Barbara (Uniklinik Köln (Colònia, Alemanya)) ;
Rhiem, Kerstin (University Hospital of Cologne, Cologne, Germany) ;
Engel, Christoph (University of Leipzig) ;
Meindl, Alfons (Technical University Munich) ;
Ditsch, Nina (Ludwig-Maximilian University Munich) ;
Arnold, Norbert (Kiel University Medical Center Schleswig-Holstein) ;
Plendl, Hansjoerg J. (Kiel University Medical Center Schleswig-Holstein) ;
Niederacher, Dieter (University Hospital of Düsseldorf (Alemanya)) ;
Sutter, Christian (Heidelberg University Hospital (Alemanya)) ;
Wang-Gohrke, Shan (University Hospital of Ulm (Alemanya)) ;
Steinemann, Doris (Institute of Cell and Molecular Pathology, Hannover) ;
Preisler-Adams, Sabine (University of Münster) ;
Kast, Karin (Technical University Dresden) ;
Varon-Mateeva, Raymonda (Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin) ;
Gehrig, Andrea (Centre of Familial Breast and Ovarian Cancer, Institute of Human Genetics, University Würzburg, Würzburg, Germany) ;
Bojesen, Anders (Vejle Hospital, Vejle) ;
Pedersen, Inge Sokilde (Aalborg University Hospital (Dinamarca)) ;
Sunde, Lone (Aarhus University Hospital (Aarhus, Dinamarca)) ;
Jensen, Uffe Birk (Aarhus University Hospital (Aarhus, Dinamarca)) ;
Thomassen, Mads (Odense University Hospital (Dinamarca)) ;
Kruse, Torben A. (Odense University Hospital (Dinamarca)) ;
Foretova, Lenka (Masaryk Memorial Cancer Institute (Brno, República Txeca)) ;
Peterlongo, Paolo (Fondazione Istituto di Oncologia MolecolarE, Milan) ;
Bernard, Loris (Istituto Europeo di Oncologia, Milan) ;
Peissel, Bernard (Fondazione Istituto Nazionale Tumori, Milan) ;
Scuvera, Giulietta (Fondazione Istituto Nazionale Tumori, Milan) ;
Manoukian, Siranoush (Fondazione Istituto Nazionale Tumori, Milan) ;
Radice, Paolo (Fondazione Istituto Nazionale Tumori, Milan) ;
Ottini, Laura ("Sapienza" University, Rome) ;
Montagna, Marco (Istituto Oncologico Veneto, Padua) ;
Agata, Simona (Istituto Oncologico Veneto, Padua) ;
Maugard, Christine (Hopitaux Universitaire de Strasbourg) ;
Simard, Jacques (Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City) ;
Soucy, Penny (Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City) ;
Berger, Andreas (Medical University of Vienna) ;
Fink-Retter, Anneliese (Medical University of Vienna) ;
Singer, Christian F. (Medical University of Vienna) ;
Rappaport, Christine (Medical University of Vienna) ;
Geschwantler-Kaulich, Daphne (Medical University of Vienna) ;
Tea, Muy-Kheng (Medical University of Vienna) ;
Pfeiler, Georg (Medical University of Vienna) ;
John, Esther M. (Cancer Prevention Institute of California) ;
Miron, Alex (Dana-Farber Cancer Institute, Boston, Massachusetts) ;
Neuhausen, Susan L. (Beckman Research Institute of City of Hope (Duarte, Estats Units d'Amèrica)) ;
Terry, Mary Beth (Columbia University) ;
Chung, Wendy (Columbia University) ;
Daly, Mary B. (Fox Chase Cancer Center, Philadelphia, Pennsylvania) ;
Goldgar, David E. (University of Utah School of Medicine, Salt Lake City) ;
Janavicius, Ramunas (Vilnius University Hospital Santariskiu Clinics) ;
Dorfling, Cecilia M. (University of Pretoria, Arcadia) ;
van Rensburg, Elisabeth J. (University of Pretoria, Arcadia) ;
Fostira, Florentia (National Centre for Scientific Research Demokritos, Athens) ;
Konstantopoulou, Irene (National Centre for Scientific Research Demokritos, Athens) ;
Garber, Judy (Harvard Medical School, Boston) ;
Godwin, Andrew K. (University of Kansas Medical Center, Kansas City) ;
Olah, Edith (National Institute of Oncology, Budapest) ;
Narod, Steven A. (University of Toronto) ;
Rennert, Gad (Clalit National Israeli Cancer Control Center) ;
Paluch, Shani Shimon (Chaim Sheba Medical Center, Ramat Gan) ;
Laitman, Yael (Institute of Human Genetics, Ramat Gan) ;
Friedman, Eitan (Tel Aviv University, Ramat Aviv) ;
Liljegren, Annelie (Karolinska University Hospital and Karolinska Institutet (Suècia)) ;
Rantala, Johanna (Karolinska University Hospital and Karolinska Institutet (Suècia)) ;
Stenmark-Askmalm, Marie (Linköping University, Sweeden) ;
Loman, Niklas (Lund University Hospital, Sweeden) ;
Imyanitov, Evgeny N. (N.N. Petrov Institute of Oncology, St.-Petersburg) ;
Hamann, Ute (German Cancer Research Center (DKFZ), Heidelberg) ;
Spurdle, Amanda B. (Queensland Institute of Medical Research (QIMR) Berghofer Medical Research Institute, Brisbane) ;
Healey, Sue (Queensland Institute of Medical Research (QIMR) Berghofer Medical Research Institute, Brisbane) ;
Weitzel, Jeffrey N. (Clinical Cancer Genetics, City of Hope, Duarte, California) ;
Herzog, Josef (Clinical Cancer Genetics, City of Hope, Duarte, California) ;
Margileth, David (St. Joseph Hospital of Orange, Duarte, California) ;
Gorrini, Chiara (University Health Network, Toronto) ;
Esteller, M (Institució Catalana de Recerca i Estudis Avançats) ;
Gómez Moruno, Antonio (Institut d'Investigació Biomèdica de Bellvitge) ;
Sayols, Sergi (Institut d'Investigació Biomèdica de Bellvitge) ;
Vidal, Enrique (Institut d'Investigació Biomèdica de Bellvitge) ;
Heyn, Holger (Institut d'Investigació Biomèdica de Bellvitge) ;
Stoppa-Lyonnet, Dominique (Université Paris Descartes, Sorbonne Paris Cité, Paris, France) ;
Léoné, Melanie (Hospices Civils de Lyon-Centre Léon Bérard, Lyon) ;
Barjhoux, Laure (Université Lyon 1) ;
Fassy-Colcombet, Marion (Institut Curie, Paris) ;
De Pauw, Antoine (Institut Curie, Paris) ;
Lasset, Christine (Université Lyon 1) ;
Ferrer, Sandra Fert (Hôtel Dieu Centre Hospitalier, Chambéry) ;
Castera, Laurent (Department of Tumour Biology, Institut Curie, Paris) ;
Berthet, Pascaline (Centre François Baclesse, Caen, France) ;
Cornelis, François (Genetic Unit, Avicenne Hospital, Clermont-Ferrand) ;
Bignon, Yves-Jean (Université de Clermont-Ferrand) ;
Damiola, Francesca (Centre de Recherche en Cancérologie de Lyon) ;
Mazoyer, Sylvie (Centre de Recherche en Cancérologie de Lyon) ;
Sinilnikova, Olga M. (Centre de Recherche en Cancérologie de Lyon) ;
Maxwell, Christopher A. (University of British Columbia, Vancouver) ;
Vijai, Joseph (Memorial Sloan-Kettering Cancer Center, New York) ;
Robson, Mark (Memorial Sloan-Kettering Cancer Center, New York) ;
Kauff, Noah (Memorial Sloan-Kettering Cancer Center, New York) ;
Corines, Marina (Memorial Sloan-Kettering Cancer Center, New York) ;
Villano, Danylko (Memorial Sloan-Kettering Cancer Center, New York) ;
Cunningham, Julie M. (Mayo Clinic, Rochester, Minnesota, United States of America) ;
Lee, Adam (Mayo Clinic, Rochester, Minnesota) ;
Lindor, Noralane (Mayo Clinic, Scottsdale, Arizona) ;
Lázaro, Conxi (Institut d'Investigació Biomèdica de Bellvitge) ;
Easton, Douglas F. (University of Cambridge) ;
Offit, Kenneth (Memorial Sloan-Kettering Cancer Center, New York) ;
Chenevix-Trench, Georgia (Queensland Institute of Medical Research, Brisbane, Australia) ;
Couch, Fergus J. (Mayo Clinic, Rochester, Minnesota) ;
Antoniou, Antonis C. (University of Cambridge) ;
Pujana, Miguel Angel (Institut d'Investigació Biomèdica de Bellvitge)
While interplay between BRCA1 and AURKA-RHAMM-TPX2-TUBG1 regulates mammary epithelial polarization, common genetic variation in HMMR (gene product RHAMM) may be associated with risk of breast cancer in BRCA1 mutation carriers. [...]
2015 -  10.1371/journal.pone.0120020
PloS one, Vol. 10 (april 2015)
|
|
|
2.
|
|
14 p, 2.9 MB |
Exploring the link between MORF4L1 and risk of breast cancer
/
Martrat, Griselda (Institut d'Investigació Biomèdica de Bellvitge) ;
Maxwell, Christopher A. (Institut d'Investigació Biomèdica de Bellvitge) ;
Tominaga, Emiko (The University of Texas Health Science Center at San Antonio) ;
Porta de la Riva, Montserrat (Institut d'Investigació Biomèdica de Bellvitge) ;
Bonifaci, Núria (Institut d'Investigació Biomèdica de Bellvitge) ;
Gomez-Baldo, Laia (Institut d'Investigació Biomèdica de Bellvitge) ;
Bogliolo, Massimo (Universitat Autònoma de Barcelona. Departament de Genètica i de Microbiologia) ;
Lazaro, Conxi (Institut d'Investigació Biomèdica de Bellvitge) ;
Blanco Guillermo, Ignacio (Institut d'Investigació Biomèdica de Bellvitge) ;
Brunet, Joan (Hospital Universitari de Girona Doctor Josep Trueta) ;
Aguilar, Helena (Institut d'Investigació Biomèdica de Bellvitge) ;
Fernández-Rodríguez, Juana (Hospital Universitari de Girona Doctor Josep Trueta) ;
Seal, Sheila (Institute of Cancer Research (Sutton, Regne Unit)) ;
Renwick, Anthony (Institute of Cancer Research (Sutton, Regne Unit)) ;
Rahman, Nazneen (Institute of Cancer Research (Sutton, Regne Unit)) ;
Kühl, Julia (University of Würzburg. Department of Human Genetics (Würzburg, Alemanya)) ;
Neveling, Kornelia (University of Würzburg. Department of Human Genetics (Würzburg, Alemanya)) ;
Schindler, Detlev (University of Würzburg. Department of Human Genetics (Würzburg, Alemanya)) ;
Ramírez de Haro, Ma. José (María José) (Universitat Autònoma de Barcelona. Departament de Genètica i de Microbiologia) ;
Castellà, Maria (Universitat Autònoma de Barcelona. Departament de Genètica i de Microbiologia) ;
Hernández Viedma, Gonzalo (Universitat Autònoma de Barcelona. Departament de Genètica i de Microbiologia) ;
Easton, Douglas F. (University of Cambridge. Department of Public Health and Primary Care) ;
Peock, Susan (University of Cambridge. Department of Public Health and Primary Care) ;
Cook, Margaret (University of Cambridge. Department of Public Health and Primary Care) ;
Oliver, Clare T. (University of Cambridge. Department of Public Health and Primary Care) ;
Frost, Debra (University of Cambridge. Department of Public Health and Primary Care) ;
Platte, Radka (University of Cambridge. Department of Oncology) ;
Evans, D. Gareth (Central Manchester University Hospitals NHS Foundation Trust (Manchester, Regne Unit)) ;
Lalloo, Fiona (Central Manchester University Hospitals NHS Foundation Trust (Manchester, Regne Unit)) ;
Eeles, Rosalind (The Institute of Cancer Research (Sutton, Regne Unit)) ;
Izatt, Louise (Guy's and St Thomas NHS Foundation Trust (Londres, Regne Unit)) ;
Chu, Carol (Yorkshire Regional Genetics Service (Leeds, Regne Unit)) ;
Davids, Rosemarie (Ferguson-Smith Centre for Clinical Genetics (Glasgow, Regne Unit)) ;
Ong, Kai-Ren (Birmingham Women's Hospital) ;
Cook, Jackie (Sheffield Children's Hospital (Sheffield, Regne Unit)) ;
Douglas, Fiona (Newcastle Upon Tyne Hospitals NHS Trust (Newcastle, Regne Unit)) ;
Hodgson, Shirley (University of London. St George's Hospital) ;
Brewer, Carole (Royal Devon & Exeter Hospital (Exeter, Regne Unit)) ;
Morrison, Patrick J. (Northern Ireland Regional Genetics Centre (Belfast, Regne Unit)) ;
Porteous, Mary (South East of Scotland Regional Genetics Service (Edimburg, Regne Unit)) ;
Peterlongo, Paolo (Fondazione IRCCS Istituto Nazionale Tumori (Milà, Itàlia)) ;
Manoukian, Siranoush (Fondazione IRCCS INT (Milà, Itàlia)) ;
Peissel, Bernard (Fondazione IRCCS INT (Milà, Itàlia)) ;
Zaffaroni, Daniela (Fondazione IRCCS INT (Milà, Itàlia)) ;
Roversi, Gaia (Fondazione IRCCS INT (Milà, Itàlia)) ;
Barile, Monica (Istituto Europeo di Oncologia (Milà, Itàlia)) ;
Viel, Alessandra (Centro di Riferimento Oncologico (Aviano, Itàlia)) ;
Pasini, Barbara (University of Turin. Department of Genetics, Biology and Biochemistry (Torí, Itàlia)) ;
Ottini, Laura (Sapienza University of Rome. Department of Molecular Medicine) ;
Putignano, Anna Laura (University of Florence. Department of Clinical Physiopathology (Florència, Itàlia)) ;
Savarese, Antonella (Regina Elena Cancer Institute (Roma, Itàlia)) ;
Bernard, Loris (IEO. Department of Experimental Oncology (Milà, Itàlia)) ;
Radice, Paolo (Fondazione IRCCS Istituto Nazionale Tumori (Milà, Itàlia)) ;
Healey, Sue (Queensland Institute of Medical Research. Division of Genetics and Population Health (Brisbane, Austràlia)) ;
Spurdle, Amanda (Queensland Institute of Medical Research. Division of Genetics and Population Health (Brisbane, Austràlia)) ;
Chen, Xiaoqing (Queensland Institute of Medical Research. Division of Genetics and Population Health (Brisbane, Austràlia)) ;
Beesley, Jonathan (Queensland Institute of Medical Research. Division of Genetics and Population Health (Brisbane, Austràlia)) ;
Rookus, Matti A. (The Netherlands Cancer Institute (Amsterdam, Països Baixos)) ;
Verhoef, Senno (The Netherlands Cancer Institute. Family Cancer Clinic (Amsterdam, Països Baixos)) ;
Tilanus-Linthorst, Madeleine A. (Erasmus MC-Daniel den Hoed Cancer Center (Rotterdam, Països Baixos)) ;
Vreeswijk, Maaike P. (Leiden University Medical Center. Center for Human and Clinical Genetics (Leiden, Països Baixos)) ;
Asperen, Christi J. (Leiden University Medical Center. Center for Human and Clinical Genetics (Leiden, Països Baixos)) ;
Bodmer, Danielle (Radboud University Nijmegen Medical Center. Department of Human Genetics (Nijmegen, Països Baixos)) ;
Ausems, Margreet G. E. M. (University Medical Center Utrecht. Department of Medical Genetics (Utrecht, Països Baixos)) ;
van Os, Theo A. (Academic Medical Center, Department of Clinical Genetics (Amsterdam, Països Baixos)) ;
Blok, Marinus J. (University Hospital Maastricht. Department of Clinical Genetics (Maastricht, Països Baixos)) ;
Meijers-Heijboer, Hanne E. J. (VU Medical Center. Department of Clinical Genetics (Amsterdam, Països Baixos)) ;
Hogervorst, Frans B. L. (The Netherlands Cancer Institute. Family Cancer Clinic (Amsterdam, Països Baixos)) ;
Goldgar, David E. (University of Utah School of Medicine. Department of Dermatology (Salt Lake City, Estats Units d'Amèrica)) ;
Buys, Saundra (Huntsman Cancer Institute (Salt Lake City, Estats Units d'Amèrica)) ;
John, Esther M. (Cancer Prevention Institute of California (Fremont, Estats Units d'Amèrica)) ;
Miron, Alexander (Dana-Farber Cancer Institute (Boston, Estats Units d'Amèrica). Department of Cancer Biology) ;
Southey, Melissa (The University of Melbourne. Melbourne School of Population Health (Austràlia)) ;
Daly, Mary B. (Fox Chase Cancer Center. Division of Population Science (Philadelphia, Estats Units d'Amèrica)) ;
Harbst, Katja (Lund University. Department of Oncology (Lund, Suècia)) ;
Borg, Åke (Lund University. Department of Oncology (Lund, Suècia)) ;
Rantala, Johanna (Karolinska University Hospital and Karolinska Institutet (Suècia)) ;
Barbany-Bustinza, Gisela (Karolinska University Hospital and Karolinska Institutet (Suècia)) ;
Ehrencrona, Hans (Uppsala University. Departament of Genetics and Pathology (Uppsala, Suècia)) ;
Stenmark-Askmalm, Marie (Hälsouniversitetet Universitetssjukhuset. Department of Oncology (Linköping, Suècia)) ;
Kaufman, Bella (Chaim Sheba Medical Center. The Institute of Oncology (Ramat Gan, Israel)) ;
Laitman, Yael (Chaim Sheba Medical Center (Israel)) ;
Milgrom, Roni (Chaim Sheba Medical Center (Israel)) ;
Friedman, Eitan (Chaim Sheba Medical Center (Israel)) ;
Domchek, Susan M. (University of Pennsylvania School of Medicine. Abramson Cancer Center (Philadelphia, Estats Units d'Amèrica)) ;
Nathanson, Katherine L. (University of Pennsylvania School of Medicine. Abramson Cancer Center (Philadelphia, Estats Units d'Amèrica)) ;
Rebbeck, Timothy R. (University of Pennsylvania School of Medicine. Abramson Cancer Center (Philadelphia, Estats Units d'Amèrica)) ;
Johannsson, Oskar (20A Landspitali-LSH v/Hringbraut. Department of Oncology (Reykjavik, Islàndia)) ;
Couch, Fergus J. (Mayo Clinic. Department of Laboratory Medicine and Pathology (Rochester, Estats Units d'Amèrica)) ;
Wang, Xianshu (Mayo Clinic. Department of Laboratory Medicine and Pathology (Rochester, Estats Units d'Amèrica)) ;
Fredericksen, Zachary (Mayo Clinic. Department of Health Sciences Research (Rochester, Estats Units d'Amèrica)) ;
Cuadras, Daniel (Institut d'Investigació Biomèdica de Bellvitge) ;
Morros, Rosa (South East of Scotland Regional Genetics Service, Western General Hospital (Edimburg, Regne Unit)) ;
Pientka, Friederike K. (University of Lübeck. Center for Structural and Cell Biology in Medicine (Lübeck, Alemanya)) ;
Depping, Reinhard (University of Lübeck. Center for Structural and Cell Biology in Medicine (Lübeck, Alemanya)) ;
Caldes, Trinidad (Hospital Clínico San Carlos (Madrid)) ;
Osorio, Ana (Centro Nacional de Investigaciones Oncológicas) ;
Benitez, Javier (Centro Nacional de Investigaciones Oncológicas) ;
Bueren, Juan (Centro de Investigaciones Energéticas, Medioambientales, y Tecnológicas (Madrid, Espanya)) ;
Heikkinen, Tuomas (Helsinki University Central Hospital. Department of Obstetrics and Gynecology (Helsinki, Finlàndia)) ;
Surrallés i Calonge, Jordi (Universitat Autònoma de Barcelona. Departament de Genètica i de Microbiologia) ;
Pujana, Miguel Angel (Institut d'Investigació Biomèdica de Bellvitge) ;
Tominaga, Kaoru (The University of Texas Health Science Center at San Antonio) ;
Cerón, Julián (Institut d'Investigació Biomèdica de Bellvitge) ;
Antoniou, Antonis C. (University of Cambridge. Department of Public Health and Primary Care) ;
Fert Ferrer, Sandra (Hôtel Dieu Centre Hospitalier (Chambéry, França)) ;
Collonge-Rame, Marie-Agnès (Centre Hospitalier Universitaire de Besançon (Besançon, França)) ;
Mortemousque, Isabelle (Centre Hospitalier Universitaire Bretonneau (Tours, França)) ;
McGuffog, Lesley (University of Cambridge. Department of Public Health and Primary Care) ;
Chenevix-Trench, Georgia (Queensland Institute of Medical Research (Brisbane, Austràlia)) ;
Pereira-Smith, Olivia M. (The University of Texas Health Science Center at San Antonio) ;
Nevanlinna, Heli (Helsinki University Central Hospital. Department of Obstetrics and Gynecology (Helsinki, Finlàndia)) ;
Hamann, Ute (Deutsches Krebsforschungszentrum (Heidelberg, Alemanya)) ;
Torres, Diana (Pontificia Universidad Javeriana. Instituto de Genética Humana (Bogota, Colòmbia)) ;
Caligo, Maria (University Hospital of Pisa (Pisa, Itàlia)) ;
Godwin, Andrew K. (University of Kansas Medical Center. Department of Pathology and Laboratory MedicineCenter (Kansas, Estats Units d'Amèrica)) ;
Imyanitov, Evgeny N. (N.N. Petrov Institute of Oncology. Laboratory of Molecular Oncology (Sant Petersburg, Rússia)) ;
Janavicius, Ramunas (Vilnius University Hospital Santariskiu Clinics. Hematology, Oncology and Transfusion Medicine Center (Vilnius, Lituània)) ;
Sinilnikova, Olga M. (Centre Hospitalier Universitaire de Lyon. Unité Mixte de Génétique Constitutionnelle des Cancers Fréquents (Lyon, França)) ;
Stoppa-Lyonnet, Dominique (Institut Curie) ;
Mazoyer, Sylvie (Université Lyon 1. Cancer Research Center of Lyon (Lyon, França)) ;
Verny-Pierre, Carole (Université Lyon 1. Cancer Research Center of Lyon (Lyon, França)) ;
Castera, Laurent (Institut Curie) ;
De Pauw, Antoine (Institut Curie) ;
Bignon, Yves-Jean (Université de Clermont-Ferrand. Département d'Oncogénétique (Clermont-Ferrand, França)) ;
Uhrhammer, Nancy (Université de Clermont-Ferrand. Département d'Oncogénétique (Clermont-Ferrand, França)) ;
Peyrat, Jean-Philippe (Centre Oscar Lambret. Laboratoire d'Oncologie Moléculaire Humaine (Lille, França)) ;
Vennin, Philippe (Centre Oscar Lambret. Consultation d'Oncogénétique (Lille, França)) ;
The Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer (kConFab) ;
The Netherlands Cancer Institute.
Hereditary Breast and Ovarian Cancer Group (HEBON) ;
University of Utah School of Medicine.
Breast Cancer Family Registry (Salt Lake City, Estats Units d'Amèrica) ;
Lund University.
Swedish Breast Cancer Study (Lund, Suècia) ;
Fédération Nationale des Centres de Lutte Contre le Cancer.
Groupe Génétique et Cancer (Lyon, França)
Introduction: Proteins encoded by Fanconi anemia (FA) and/or breast cancer (BrCa) susceptibility genes cooperate in a common DNA damage repair signaling pathway. To gain deeper insight into this pathway and its influence on cancer risk, we searched for novel components through protein physical interaction screens. [...]
2011 - 10.1186/bcr2862
Breast cancer research, Vol. 13, Núm. R40 (4 2011) -14
|
|
visitant ::
identificació
alerta personal via correu electrònic o subscribiu-vos al 
canal RSS.
